Digerati Technologies, Inc. (OTC: DTGI) (“Digerati” or the “Company”), a provider of cloud services specializing in Unified Communications as a Service (“UCaaS”) solutions for the small to medium-sized business (“SMB”) market, announced today the passing of its Founder and Chief Executive Officer (CEO) Arthur L. Smith on February 16, 2025. https://mma.prnewswire.com/media/2626770/Digerati_Technologies_Logo.jpg Mr. Smith was a […]

The game-changing super shoe features Saucony's all-new IncrediRUN™ foam, designed to unlock every runner's performance potential Whether aiming for a personal best or keeping pace with the local run crew, everyone aspires to feel fast. Hearing its consumer's aspirations, Saucony, a leading global performance running lifestyle brand, delivers with its highly anticipated global launch of

Halifax Group (“Halifax”) announced today that it received a BluWave 2025 Top Private Equity Innovator Award, which recognizes select private equity firms for exemplary innovation and leadership. https://mma.prnewswire.com/media/2406166/Halifax_Group_Logov1.jpg BluWave, which partners with more than 500 leading private equity firms, is the business builders' network that connects the private equity industry with best-in-class talent, industry consultants

Award nominations are now open for Platform//2025 Scale Computing, the market leader in edge computing, virtualization, and hyperconverged solutions, today announced it is now accepting nominations for the third annual Scale Computing Platform Summit Awards. The awards ceremony will take place May 15, 2025 at Resorts World in Las Vegas at Scale Computing Platform Summit

Oncor Electric Delivery Company LLC (“Oncor”) today reported twelve months ended December 31, 2024 net income of $968 million compared to twelve months ended December 31, 2023 net income of $864 million. This $104 million increase was driven by overall higher revenues primarily attributable to updated interim rates to reflect increases in invested capital, increases

New release introduces breakthrough innovations in proof automation, counterexample generation, and decision procedures, to elevate AI-driven logical analysis industry standards Imandra Inc., the AI startup pioneering neurosymbolic reasoning, today announced ImandraX, the latest major release of its flagship Imandra automated reasoning engine. ImandraX marks a significant advancement in AI-driven logical reasoning, introducing powerful new reasoning

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory Bowel Disease (“IBD”) and other immune-mediated diseases, today announced that management will participate in the following upcoming investor conferences: Event: TD Cowen 45th Annual Healthcare ConferenceFormat: Fireside chat and 1×1 meetingsDate/Time:

Axiad's PKI-based authentication enables scalability and flexibility in large-scale enterprise environments, elevates user experience and streamlines user access control Frost & Sullivan recently analyzed the public key infrastructure (PKI)-based authentication industry and, based on its research, recognizes Axiad with the 2025 Global Customer Value Leadership Award. The company, originally founded as an integrator of Identity

New Episode Highlights Student Experiences, Academic Excellence, and Vibrant Campus Life Southwestern Oklahoma State University (SWOSU) proudly announces its feature in the 13th season of The College Tour, now available on Amazon Prime Video. This milestone marks SWOSU as the first public university in Oklahoma to be showcased on the acclaimed series, offering viewers an

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, “CARsgen Therapeutics”), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces reaching agreements with an investment fund managed by Zhuhai Hengqin SB Xinchuang Equity Investment Management Enterprise (Limited Partnership) (“Zhuhai SB Xinchuang”) to jointly invest in UCARsgen Biotech Limited